|
Volumn 791, Issue 1-2, 2003, Pages 245-253
|
Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: Application to a clinical trial
|
Author keywords
4 Hydroxytamoxifen; N Desmethyltamoxifen; Tamoxifen; Z 4 Hydroxy N desmethyltamoxifen
|
Indexed keywords
FLUORESCENCE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
PATIENT TREATMENT;
PLASMAS;
TUMORS;
FLUORESCENCE DETECTION;
METABOLITES;
4 HYDROXYTAMOXIFEN;
ACETONITRILE;
BUFFER;
DRUG METABOLITE;
NORTAMOXIFEN;
POTASSIUM DIHYDROGEN PHOSPHATE;
PROPRANOLOL;
TAMOXIFEN CITRATE;
TAMOXIFEN DERIVATIVE;
ACCURACY;
ANALYSIS OF VARIANCE;
ARTICLE;
BREAST CANCER;
CANCER PATIENT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FLUORESCENCE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LIQUID LIQUID EXTRACTION;
PH;
PLASMA;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REPRODUCIBILITY;
SEPARATION TECHNIQUE;
|
EID: 0038697813
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/S1570-0232(03)00218-6 Document Type: Article |
Times cited : (93)
|
References (16)
|